Description
PALOPAG 200 MCG is a medication that contains the active ingredient Palonosetron, which is primarily used as an antiemetic. It is designed to prevent nausea and vomiting, typically induced by chemotherapy or other medical treatments like radiation. At a dosage of 200 micrograms (MCG), PALOPAG works by blocking serotonin receptors in the brain and gastrointestinal tract, which are involved in triggering vomiting. It is generally administered as an intravenous injection by healthcare professionals in clinical settings, offering relief to patients undergoing cancer treatment. The drug has a long half-life, which allows it to provide extended protection against nausea and vomiting over a period of time. As with any medication, it's important to follow the prescribed dosage and consult a healthcare provider about potential side effects or interactions with other medications.
.png)
.jpg)
.jpg)
 100 IU 3 ML.webp)
 400MG.jpg)
.jpg)
.jpg)
.jpg)
.webp)
.jpg)
.jpeg)
.jpeg)
.jpg)
.webp)
.webp)
.jpg)
.jpeg)
.jpeg)
Change Language